Skip to main content
Erschienen in: Lung 2/2017

09.02.2017

Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea

verfasst von: Eun Hye Lee, Jung Mo Lee, Young Ae Kang, Ah Young Leem, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Song Yee Kim

Erschienen in: Lung | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

South Korea has an increasing prevalence of diabetes and a relatively high burden of tuberculosis. We aimed to determine the prevalence of diabetes in patients with active pulmonary tuberculosis (PTB) and examine the effect of diabetes on tuberculosis treatment outcomes.

Setting and Design

Data from patients ≥30 years diagnosed with and treated for PTB between January 2010 and December 2012 at Severance Hospital, a 2000-bed tertiary referral hospital in Seoul, South Korea, were analyzed and compared with data from a contemporaneous general population sample extracted from KNHANES V.

Results

Diabetes prevalence was 24.2% (252/1044) among patients with PTB and 11.6% (1700/14,655) among controls. Diabetes [odds ratios (OR) 2.56, 95% confidence interval (CI) 1.56–4.21, P < 0.001], male sex (OR 1.93, 95% CI 1.08–3.44, P = 0.027), and cavitary disease (OR 2.08, 95% CI 1.29–3.35, P = 0.003) were significant risk factors for 2-month culture positivity. Diabetes was the only factor associated with unsuccessful treatment outcomes (OR 1.67, 95% CI 1.03–2.70, P = 0.039).

Conclusion

The prevalence of diabetes was markedly higher in patients with PTB than in a sample of the general South Korean population. Diabetes may delay sputum conversion and adversely affect treatment outcomes; detection and management of diabetes in patients with PTB is crucial.
Literatur
1.
Zurück zum Zitat World Health Organisation (2015) Global tuberculosis report 2015. World Health Organization, Geneva World Health Organisation (2015) Global tuberculosis report 2015. World Health Organization, Geneva
4.
Zurück zum Zitat Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):1091–1101CrossRef Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):1091–1101CrossRef
6.
Zurück zum Zitat American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1:S64–S71CrossRef American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1:S64–S71CrossRef
7.
Zurück zum Zitat Blumberg HM, Burman WJ, Chaisson RE et al (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167(4):603–662CrossRefPubMed Blumberg HM, Burman WJ, Chaisson RE et al (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167(4):603–662CrossRefPubMed
8.
Zurück zum Zitat Jo KW, Yoo JW, Hong Y et al (2014) Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med 108(4):654–659CrossRefPubMed Jo KW, Yoo JW, Hong Y et al (2014) Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med 108(4):654–659CrossRefPubMed
9.
Zurück zum Zitat Alisjahbana B, van Crevel R, Sahiratmadja E et al (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 10(6):696–700PubMed Alisjahbana B, van Crevel R, Sahiratmadja E et al (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 10(6):696–700PubMed
10.
Zurück zum Zitat Sulaiman SA, Khan AH, Muttalif AR et al (2013) Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci 345(4):321–325CrossRefPubMed Sulaiman SA, Khan AH, Muttalif AR et al (2013) Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci 345(4):321–325CrossRefPubMed
11.
Zurück zum Zitat Kornfeld H, West K, Kane K et al (2016) High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (E.S) Study. Chest 149(6):1501–1508CrossRefPubMed Kornfeld H, West K, Kane K et al (2016) High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (E.S) Study. Chest 149(6):1501–1508CrossRefPubMed
12.
Zurück zum Zitat Kim SJ, Hong YP, Lew WJ et al (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 76(6):529–533CrossRefPubMed Kim SJ, Hong YP, Lew WJ et al (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 76(6):529–533CrossRefPubMed
13.
14.
Zurück zum Zitat Chang FY, Shaio MF (1995) Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28(2):137–146CrossRefPubMed Chang FY, Shaio MF (1995) Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28(2):137–146CrossRefPubMed
15.
Zurück zum Zitat Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed
16.
Zurück zum Zitat Wang CH, Yu CT, Lin HC et al (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242CrossRefPubMed Wang CH, Yu CT, Lin HC et al (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242CrossRefPubMed
17.
Zurück zum Zitat Alisjahbana B, Sahiratmadja E, Nelwan EJ et al (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435CrossRefPubMed Alisjahbana B, Sahiratmadja E, Nelwan EJ et al (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435CrossRefPubMed
18.
Zurück zum Zitat Rekha VVB, Balasubramanian R, Swaminathan S et al (2007) Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res 126(5):452–458 Rekha VVB, Balasubramanian R, Swaminathan S et al (2007) Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res 126(5):452–458
19.
Zurück zum Zitat Singla R, Khan N, Al-Sharif N et al (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed Singla R, Khan N, Al-Sharif N et al (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed
20.
Zurück zum Zitat Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220CrossRefPubMed Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220CrossRefPubMed
21.
Zurück zum Zitat Shariff NM, Safian N (2015) Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: a case control study. Int J Mycobacteriol 4(4):323–329CrossRefPubMed Shariff NM, Safian N (2015) Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: a case control study. Int J Mycobacteriol 4(4):323–329CrossRefPubMed
22.
Zurück zum Zitat Viswanathan V, Vigneswari A, Selvan K et al (2014) Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis—a report from South India. J Diabetes Complicat 28(2):162–165CrossRefPubMed Viswanathan V, Vigneswari A, Selvan K et al (2014) Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis—a report from South India. J Diabetes Complicat 28(2):162–165CrossRefPubMed
23.
Zurück zum Zitat Jiménez-Corona ME, Cruz-Hervert LP, García-García L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220CrossRefPubMed Jiménez-Corona ME, Cruz-Hervert LP, García-García L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220CrossRefPubMed
24.
Zurück zum Zitat Dooley KE, Tang T, Golub JE et al (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMedPubMedCentral Dooley KE, Tang T, Golub JE et al (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMedPubMedCentral
25.
Zurück zum Zitat Güler M, Ünsal E, Dursun B et al (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235CrossRefPubMed Güler M, Ünsal E, Dursun B et al (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235CrossRefPubMed
26.
Zurück zum Zitat Restrepo BI, Fisher-Hoch SP, Smith B et al (2008) Short report: Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMedPubMedCentral Restrepo BI, Fisher-Hoch SP, Smith B et al (2008) Short report: Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMedPubMedCentral
27.
Zurück zum Zitat Leung CC, Lam TH, Chan WM et al (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494CrossRefPubMed Leung CC, Lam TH, Chan WM et al (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494CrossRefPubMed
28.
Zurück zum Zitat Restrepo BI, Fisher-Hoch SP, Pino PA et al (2008) Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641CrossRefPubMedPubMedCentral Restrepo BI, Fisher-Hoch SP, Pino PA et al (2008) Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yamashiro S, Kawakami K, Uezu K et al (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64CrossRefPubMedPubMedCentral Yamashiro S, Kawakami K, Uezu K et al (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64CrossRefPubMedPubMedCentral
Metadaten
Titel
Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea
verfasst von
Eun Hye Lee
Jung Mo Lee
Young Ae Kang
Ah Young Leem
Eun Young Kim
Ji Ye Jung
Moo Suk Park
Young Sam Kim
Se Kyu Kim
Joon Chang
Song Yee Kim
Publikationsdatum
09.02.2017
Verlag
Springer US
Erschienen in
Lung / Ausgabe 2/2017
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-017-9978-4

Weitere Artikel der Ausgabe 2/2017

Lung 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.